Loerrach, Germany

Thomas Hartung

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Hoffmann-La Roche Inc., ETH Zurich, Unversität Zürich. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Hartung. Retrieved from https://idiyas.com/inventor/thomas-hartung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 60.0

 

 

Average Co-Inventor Count = 8.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Journey of Thomas Hartung

Introduction: Thomas Hartung is a pioneering inventor based in Loerrach, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Thomas Hartung holds several patents in various technological domains, showcasing his continuous commitment to pushing the boundaries of innovation.

Career Highlights: With a career spanning over two decades, Thomas Hartung has established himself as a visionary inventor, consistently developing cutting-edge solutions that have revolutionized the industry.

Collaborations: Throughout his career, Thomas Hartung has collaborated with leading research institutions, universities, and tech companies, fostering a culture of innovation and knowledge sharing.

Conclusion: Thomas Hartung's relentless pursuit of innovation and his passion for creating transformative technologies have solidified his reputation as a trailblazing inventor in the global tech landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…